Latest Breaking News On - Myriam mendila - Page 1 : comparemela.com

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK

Issuer: CureVac / Key word: Study CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK.

United statesSarah fakihMyriam mendilaPatrick perezCorporate communicationsDevelopment in collaborationWorld health organizationCurevac announces dosingFirst participantSeasonal influenzaChief scientific officerJunior manager publicVice president corporate communications

CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development

Issuer: CureVac / Key word(s): Study28.05.2024 / 13:00 CET/CESTThe issuer is solely responsible for the content of this announcement.CureVac Announces Dosing of First Participant in a Phase 2 Study in Seasonal Influenza; Development in Collaboration with GSK  Phase 2 study to assess updated formulations for im.

United statesPatrick perezSarah fakihMyriam mendilaDevelopment in collaborationCurevac corporate services gmbCorporate communicationsWorld health organizationCurevac incExchange commissionDistribution servicesVac announces dosingFirst participantSeasonal influenzaChief scientific officerJunior manager public

CureVac N V (NASDAQ:CVAC) Q4 2023 Earnings Call Transcript

Operator: Greetings and welcome to the CureVac Fourth Quarter and Full Year 2023 Financial Results and Business Update Conference Call. At this time, all participants are in a listen-only mode.

Roy buchananBevan wangThaminda ramanayakeMarcus daltonAlexander zehnderMani forooharJim cramerPierre kemulaSarah fakihMyriam mendilaExchange commissionAnderson cancer centerGerman federal courtSanofi biomarin pharmaceuticalsCorporate communicationsGerman federal patent court

EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK | Company Announcement

Investegate announcements from EQS-News: CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza (H5N1); Development in Collaboration with GSK

United statesSarah fakihPatrick perezMyriam mendilaCorporate communicationsDevelopment in collaborationCurevac announces startCombined phaseAvian influenzaChief development officerJunior manager publicVice president corporate communications

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK

CureVac Announces Start of Combined Phase 1/2 Study in Avian Influenza ; Development in Collaboration with GSK
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

United statesMyriam mendilaPatrick perezSarah fakihDennis riedlCorporate communicationsExchange commissionCurevac corporate services gmbCurevac incChief development officerJunior manager publicVice president corporate communicationsCurevac manufacturing gmbhCurevac swissCurevac corporate services gmbhCurevac belgium